Navigation Links
Pharmathene Announces Publication of Phase I Study Results for Anthrax Anti-toxin Valortim®
Date:12/6/2011

ANNAPOLIS, Md., Dec. 6, 2011 /PRNewswire/ -- PharmAthene, Inc. (NYSE Amex: PIP) today announced that results from a Phase I clinical study of Valortim® were published in the December issue of Clinical and Vaccine Immunology.  The American Society for Microbiology peer-reviewed journal describes clinical data supporting the potential use of Valortim®, a fully human monoclonal antibody, as both a post-exposure prophylaxis and therapeutic treatment for anthrax infection.

"There is a strong need for additional therapeutic options for inhalational anthrax disease as current therapies, specifically antibiotics and aggressive supportive care, are not optimally effective in individuals with active, symptomatic anthrax infection. Anti-toxin therapies like Valortim® could potentially provide important protection in the event of a bioterrorism attack with anthrax," remarked Dr. Thomas Fuerst, Executive Vice President and Chief Scientific Officer.  "Our Phase I results demonstrate that a single dose of Valortim® can provide  levels of antibodies in humans that correspond to protective levels in animal models and is well tolerated.  Based on the accumulating human safety and animal efficacy data for Valortim®, we believe that it could represent an important addition to the nation's anthrax armamentarium."

Preclinical studies suggest that Valortim® has the potential to provide significant protection against anthrax infection when administered prophylactically (prior to the emergence of symptoms of anthrax infection) and also may increase survival when administered therapeutically (once symptoms become evident).  In these studies, Valortim® has been shown to protect both rabbits and monkeys against the lethal effects of anthrax infection
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. PharmAthene to Present at the Piper Jaffray 23rd Annual Healthcare Conference on November 30, 2011
2. PharmAthene to Present at the 2011 Chemical and Biological Defense Science and Technology Conference
3. PharmAthene to Host Third Quarter 2011 Conference Call and Webcast on Wednesday, November 9, 2011
4. PharmAthene Submits Legal Brief in Response to SIGA Technologies Motion for Reargument
5. PharmAthene Awarded 50% Profit Split on Worldwide Sales of Smallpox Antiviral Therapy by Delaware Chancery Court
6. PharmAthene Announces $6.5 Million Registered Direct Offering
7. PharmAthene Completes Dosing in Valortim® Phase I Clinical Trial
8. PharmAthene Provides Update on Litigation With SIGA Technologies
9. PharmAthene Presents New Anthrax Data at the 5th Annual PHEMCE Stakeholders Workshop and BARDA Industry Day
10. PharmAthene to Host Third Quarter 2010 Conference Call and Webcast on Thursday, November 11, 2010
11. PharmAthene Announces Closing of $15 Million Public Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... 2015   Physicians Rx Pharmacy ("PRxP") today ... the organization as President and Chief Executive Officer.  ... and Chief Executive Officer for Soleo Health Specialty Infusion ... Physicians Rx Pharmacy, be responsible for leading the rapidly-growing ... pleased to bring Gaston on as the President and ...
(Date:9/2/2015)... Calif. , Sept. 2, 2015 ... submission of a Marketing Authorization Application (MAA) to ... procedure for etelcalcetide (formerly AMG 416) for the ... with chronic kidney disease (CKD) on hemodialysis therapy. ... agent that can be administered intravenously. ...
(Date:9/2/2015)... 2015  Seeger Weiss LLP is reporting that Zimmer ... October 13, 2015. Since the product ... program, Zimmer NexGen knee implant surpassed FDA investigation and ... provide evidence that the product is substantially similar to ... permissions. In 2001, Zimmer began distributing ...
Breaking Medicine Technology:Gaston L. Bernstein Named President and CEO of Physicians Rx Pharmacy 2Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 2Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 3Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 4Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 5Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 6Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 7Seeger Weiss LLP Reports That Zimmer NexGen Knee MDL Bellwether Trial Date Set For October 13, 2015 2
... Calif., Jan. 3, 2012  Cutera, Inc. (NASDAQ: ... ) today announced that the companies have entered into ... of IRIDEX, global aesthetic business for approximately $5.1 million. ... $1 billion global aesthetic market, with IRIDEX, strength in ...
... 3, 2012 Reportlinker.com announces that ... available in its catalogue: ... (PE/VC) Activity in Medical Devices - ... has Increased over the Past Four ...
Cached Medicine Technology:Cutera and IRIDEX Announce Acquisition of IRIDEX' Aesthetic Business Unit 2Cutera and IRIDEX Announce Acquisition of IRIDEX' Aesthetic Business Unit 3Cutera and IRIDEX Announce Acquisition of IRIDEX' Aesthetic Business Unit 4Private Equity and Venture Capital (PE/VC) Activity in Medical Devices - Number of Investments in Smaller Companies has Increased over the Past Four Years 2Private Equity and Venture Capital (PE/VC) Activity in Medical Devices - Number of Investments in Smaller Companies has Increased over the Past Four Years 3Private Equity and Venture Capital (PE/VC) Activity in Medical Devices - Number of Investments in Smaller Companies has Increased over the Past Four Years 4Private Equity and Venture Capital (PE/VC) Activity in Medical Devices - Number of Investments in Smaller Companies has Increased over the Past Four Years 5Private Equity and Venture Capital (PE/VC) Activity in Medical Devices - Number of Investments in Smaller Companies has Increased over the Past Four Years 6Private Equity and Venture Capital (PE/VC) Activity in Medical Devices - Number of Investments in Smaller Companies has Increased over the Past Four Years 7Private Equity and Venture Capital (PE/VC) Activity in Medical Devices - Number of Investments in Smaller Companies has Increased over the Past Four Years 8Private Equity and Venture Capital (PE/VC) Activity in Medical Devices - Number of Investments in Smaller Companies has Increased over the Past Four Years 9Private Equity and Venture Capital (PE/VC) Activity in Medical Devices - Number of Investments in Smaller Companies has Increased over the Past Four Years 10Private Equity and Venture Capital (PE/VC) Activity in Medical Devices - Number of Investments in Smaller Companies has Increased over the Past Four Years 11
(Date:9/3/2015)... DC (PRWEB) , ... September 03, 2015 , ... ... the speakers for its upcoming virtual conference, “Proven Pharmacy Benefit Strategies for a ... such as CVS Health, Express Scripts and Milliman, will discuss how plan sponsors ...
(Date:9/3/2015)... ... September 03, 2015 , ... “We wish ... can impact the delicate life balance between work and leisure to the benefit ... R. Leaptrott, CEO , A LifeMinder Plus® Emergency Care Document Set duly executed ...
(Date:9/3/2015)... ... 03, 2015 , ... Representatives with State Farm Agent EJ ... Mississippi Gulf Babypalooza on September 19, 2015. , “We will be providing information ... beyond. We will be discussing setting up college funds, offering information specific to ...
(Date:9/3/2015)... ... ... Local filmmakers and now co-hosts of the up and coming podcast Path11 ... had great success in launching their Path11 Podcast with 23 episodes released since April ... is the well known Spiritual Catalyst and Linda Howe, leader in the field of ...
(Date:9/3/2015)... ... September 03, 2015 , ... Fashion designer Kim (29 ... of the most recent episode of the hit ABC series “Extreme Weight Loss” ... image of her industry. She provided herself with the motivation to transform when she ...
Breaking Medicine News(10 mins):Health News:Speakers for Upcoming AIS Virtual Conference on Pharmacy Benefit Strategies Include Executives from CVS Health, Express Scripts 2Health News:LifeMinder Plus® Announces Emergency Care Document Set Giveaway for America 2Health News:LifeMinder Plus® Announces Emergency Care Document Set Giveaway for America 3Health News:State Farm Agent EJ Roberts to Help Expecting Mothers at the Mississippi Gulf Babypalooza 2Health News:Path 11 Podcast Now Features over 20 Metaphysical Discussions on iTunes and Growing 2Health News:Path 11 Podcast Now Features over 20 Metaphysical Discussions on iTunes and Growing 3Health News:New “Extreme Weight Loss” Video Blog from the CU Anschutz Health and Wellness Center: Kim Begins with the End in Mind and Designs a Fashionable Future 2Health News:New “Extreme Weight Loss” Video Blog from the CU Anschutz Health and Wellness Center: Kim Begins with the End in Mind and Designs a Fashionable Future 3
... firm, founded by veteran attorney Bruce Abel, launches blog to help ... ... Los Angeles (Lexis Nexis) May 23, 2009 -- In ... protecting workers, rights and minimize the risk of employment litigation, ...
... HAE:TSX- Loan of US$2.5 Million Expected to Close ... Haemacure Corporation (TSX:HAE), a Montreal-based specialty bio-therapeutics company, ... Vancouver (NASDAQ: ANPI , TSX:ANP) are preparing ... loan from Angiotech to Haemacure in the amount ...
... Minnesota Chiropractic Association (MCA) recognized Dr. Joseph Sweere as ... and awards ceremony Sweere was honored for his unselfish ... Sweere is a professor in the Department of Clinical ... chairman of the Department of Occupational Health at Northwestern, ...
... Breakthrough caregiver training to revolutionize senior home care ... Assistance of Palo Alto, California released its new ... Method(TM). This system, exclusive to Home Care Assistance ... North America with an emphasis on lifestyle, healthy ...
... Helen Darling, President of the National Business Group ... is the national association representing 300 large employers - ... benefits to more than 55 million Americans workers, dependents, ... responding to what we believed were some mischaracterizations in ...
... for clues to better treatments , , FRIDAY, May 22 (HealthDay ... the protein caveolin-1 found in stromal connective tissue near a ... may provide a pathway to future treatments. , Low ... absorb things, in the stromal cells were linked to a ...
Cached Medicine News:Health News:Abel Law Offices Introduces Free Web Resource for California Employers Navigating Workplace Laws 2Health News:Haemacure Update on Proposed Collaboration and Bridge Financing 2Health News:Haemacure Update on Proposed Collaboration and Bridge Financing 3Health News:Haemacure Update on Proposed Collaboration and Bridge Financing 4Health News:Haemacure Update on Proposed Collaboration and Bridge Financing 5Health News:Dr. Joseph Sweere Receives Educator of the Year Award 2Health News:Dr. Joseph Sweere Receives Educator of the Year Award 3Health News:Home Care Assistance's Exclusive Balanced Care Method(TM) Designed to Promote Longer, Healthier Lives 2Health News:Home Care Assistance's Exclusive Balanced Care Method(TM) Designed to Promote Longer, Healthier Lives 3
Look to the intuitive iLab System to deliver the best IVUS image quickly and easily. This easy-to-use installed system with tableside controller is the Clear Choice for IVUS....
... full picture ,CardioPAL SAVI is the ... cial Intelligence, with a smart algorithm running ... on each device. The Diogenes algorithm continuously ... rate, rhythm, morphology, and p-wave abnormalities ...
A patient care system tailored to your specific needs that supports current and previous-generation ICDs and pacemakers....
The Rio Catheter is designed to simplify your intravascular interventions by removing thrombus and restoring epicardial flow to the procedure....
Medicine Products: